Product: Drugs Recipient: Cosmenic Panama Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, 2025 […]

Product: Drugs Recipient: Aesthetic Essentials Limited Hong Kong SAR China Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 […]

Product: Drugs Recipient: Glow Nest Beauty United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 Glow Nest […]

Product: Drugs Recipient: Dermax Co., Ltd China Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 Dermax Co., Ltd.: […]

Product: Drugs Recipient: AceCosm Hong Kong SAR China Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER November 3, 2025 AceCosm: This […]

Action The U.S. Food and Drug Administration (FDA) has approved Linzess (linaclotide) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation […]

Product: Drugs Recipient: onlineotcmeds.com United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States FROM: The United States Food and Drug Administration RE: […]

Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Reference #: 320-26-02 Product: Drugs Recipient: Recipient Name Ms. Denise Kwiatkowski Recipient Title Regulatory Affairs Manager Scientific Protein […]

Delivery Method: VIA UPS Reference #: 320-26-12 Product: Drugs Recipient: Recipient Name Mr. Allan Oberman Recipient Title President & Chief Executive Officer Apotex Inc. 150 Signet […]